Lv7
4980 积分 2023-04-18 加入
Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database
6个月前
已完结
Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database
7个月前
已完结
PI3K/AKT Pathway: A Potential Therapeutic Target in Cerebral Ischemia-Reperfusion Injury
8个月前
已完结
Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy
8个月前
已完结
Guyuan Jiannao Decoction improves neurovascular unit dysfunction by regulating PI3K/AKT/NF-κB signaling pathway in cerebral small vessel disease rats
8个月前
已完结
Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia
8个月前
已完结
皖公网安备34019202002308
